Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ashwani K. Gupta is active.

Publication


Featured researches published by Ashwani K. Gupta.


Proceedings of the National Academy of Sciences of the United States of America | 1999

Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2

Donald G. Munroe; Ashwani K. Gupta; Fatemeh Kooshesh; Tejal B. Vyas; Geihan Rizkalla; Hong Wang; Lidia Demchyshyn; Zhi-Jie Yang; Rajender Kamboj; Hongyun Chen; Kirk McCallum; Martin Sumner-Smith; Daniel J. Drucker; Anna E. Crivici


Archive | 1998

Mammalian edg-5 receptor homologs

Donald G. Munroe; Ashwani K. Gupta; Tejal B. Vyas; Jerold Chun


Archive | 2000

Cloned human sphingosine kinase homologues

Donald G. Munroe; Ashwani K. Gupta; Germaine R. Falzone


Archive | 1998

Identification of lysolipid receptors involved in inflammatory response

Donald G. Munroe; Rajender Kamboj; Diana Peters; Fatemeh Kooshesh; Tejal B. Vyas; Ashwani K. Gupta


Archive | 1997

Cloned glucagon-like peptide-2 receptors

Donald G. Munroe; Ashwani K. Gupta; Tejal B. Vyas; Kirk McCallum; Ermei Fan


Cancer Research | 2008

Anti-CD9 antibody, AR40A746.2.3, inhibits tumor growth in pancreatic and breast cancer models and recognizes CD9 on CD34+CD38- leukemic cancer stem cells.

Javier Menendez; Liqing Jin; Armando Poeppl; Daad Sayegh; Kevin O'Reilly; Nives Ceric; Tejal B. Vyas; Ashwani K. Gupta; Susan Hahn; David M. Young; John E. Dick; Daniel Pereira


Archive | 1998

Isolated human EDG-4 receptor and polynucletide encoding said receptor

Donald G. Munroe; Rajender Kamboj; Diana Peters; Fatemch Kooshesh; Tejal B. Vyas; Ashwani K. Gupta


Journal of Clinical Oncology | 2008

Clinical development of huARH460-16-2: A therapeutic antibody targeting the CD44 cancer stem cell antigen on high-incidence adenocarcinomas

Susan Hahn; L. A. da Cruz; Ashwani K. Gupta; B.C. Mak; L. Popp; Daniel S. Pereira; D. B. Rubinstein; D.S. Young


Cancer Research | 2018

Abstract 200: FOXD1 promotes stromal investment in clear cell renal cell carcinoma

Kyle H. Bond; Jennifer L. Fetting; Ashwani K. Gupta; Christine W. Duarte; Michele J. Karolak; Clare Bates Congdon; Ivette F. Emery; Eoghainín Ó hAinmhire; Benjamin D. Humphreys; Leif Oxburgh


Ejc Supplements | 2008

521 POSTER A monoclonal antibody targeting the breast cancer stem cell marker melanoma-associated chondroitin sulfate proteoglycan improves survival and demonstrates anti-tumor activity in vivo

Ashwani K. Gupta; Alison L. Ferry; Mitra Amoozgar; Carlos Alexandre Vieira; Daad Sayegh; J. Menendez; N. Ceric; L.A.G. da Cruz; Daniel S. Pereira; D.S. Young

Collaboration


Dive into the Ashwani K. Gupta's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tejal B. Vyas

University Health Network

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D.S. Young

University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar

Daad Sayegh

University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge